Jishuning? Cetirizine Hydrochloride Oral Solution

2025 Guangdong Alliance: Diclofenac and other drugs to continue the selection.

Medicare Category B

Wide applicability; precise dosage; convenient to take; stable absorption.

[Drug Name]

       Generic Name: Cetirizine Hydrochloride Oral Solution

[Indications]

       Seasonal allergic rhinitis、Perennial allergic rhinitis、Allergic conjunctivitis、Symptomatic treatment of pruritus and urticaria caused by allergies

[Usage and Dosage]

       Recommended for adults and children over 2 years old.

       Adults and children over 6 years: In most cases, the recommended dose is 10 ml (10 mg) once a day, taken orally. If the patient is more sensitive to adverse reactions, the dose may be split, with 5 ml (5 mg) taken twice a day—once in the morning and once in the evening.

       Children aged 2-6 years: 5 ml (5 mg) once daily; or 2.5 ml (2.5 mg) twice daily. (See the product insert for further details.)

[Contraindications]

       Contraindicated in patients who are allergic to levocetirizine, cetirizine, other piperazine derivatives, or any excipients of this product.

       Contraindicated in patients with end-stage renal disease (CLCR < 10 ml/min) and patients on dialysis.

       Contraindicated in children under 11 years old with renal impairment.

       For further details, please refer to the product insert.

[Specification]

       100 ml: 0.1 g

[Validity Period]

       24 months. After opening, the product should be consumed within 3 months and should not exceed the expiration date. Discard if expired.

[Approval Number]

       National Medicine Approval Number H20254566

Consultation hotline: +86 591 83512959